Reference
Yoshibayashi H, et al. A patient with primary breast cancer who responded remarkably well to neoadjuvant chemotherapy with FEC100 followed by abraxane. [Japanese]. Gan to Kagaku Ryoho 40: 627-629, No. 5, May 2013 [Japanese; summarised from an English abstract] - Japan
Rights and permissions
About this article
Cite this article
Paclitaxel. Reactions Weekly 1613, 224 (2016). https://doi.org/10.1007/s40278-016-20181-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-016-20181-y